Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 5
2004 7
2005 7
2006 7
2007 6
2008 6
2009 4
2010 8
2011 3
2012 9
2013 9
2014 9
2015 11
2016 7
2017 13
2018 14
2019 12
2020 12
2021 16
2022 17
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer.
Mizuta H, Okada K, Araki M, Adachi J, Takemoto A, Kutkowska J, Maruyama K, Yanagitani N, Oh-Hara T, Watanabe K, Tamai K, Friboulet L, Katayama K, Ma B, Sasakura Y, Sagae Y, Kukimoto-Niino M, Shirouzu M, Takagi S, Simizu S, Nishio M, Okuno Y, Fujita N, Katayama R. Mizuta H, et al. Among authors: takagi s. Nat Commun. 2021 Feb 24;12(1):1261. doi: 10.1038/s41467-021-21396-w. Nat Commun. 2021. PMID: 33627640 Free PMC article.
What Is Your Diagnosis?
Takagi S, Nakamura K, Takeuchi R, Hanazono K. Takagi S, et al. J Am Vet Med Assoc. 2019 Jul 1;255(1):51-53. doi: 10.2460/javma.255.1.51. J Am Vet Med Assoc. 2019. PMID: 31194664 Free article. No abstract available.
Targeting Podoplanin for the Treatment of Osteosarcoma.
Takemoto A, Takagi S, Ukaji T, Gyobu N, Kakino M, Takami M, Kobayashi A, Lebel M, Kawaguchi T, Sugawara M, Tsuji-Takayama K, Ichihara K, Funauchi Y, Ae K, Matsumoto S, Sugiura Y, Takeuchi K, Noda T, Katayama R, Fujita N. Takemoto A, et al. Among authors: takagi s. Clin Cancer Res. 2022 Jun 13;28(12):2633-2645. doi: 10.1158/1078-0432.CCR-21-4509. Clin Cancer Res. 2022. PMID: 35381070 Free PMC article.
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Maekawa N, Konnai S, Hosoya K, Kim S, Kinoshita R, Deguchi T, Owaki R, Tachibana Y, Yokokawa M, Takeuchi H, Kagawa Y, Takagi S, Ohta H, Kato Y, Yamamoto S, Yamamoto K, Suzuki Y, Okagawa T, Murata S, Ohashi K. Maekawa N, et al. Among authors: takagi s. PLoS One. 2023 Oct 4;18(10):e0291727. doi: 10.1371/journal.pone.0291727. eCollection 2023. PLoS One. 2023. PMID: 37792729 Free PMC article.
Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.
Deguchi T, Maekawa N, Konnai S, Owaki R, Hosoya K, Morishita K, Nakamura M, Okagawa T, Takeuchi H, Kim S, Kinoshita R, Tachibana Y, Yokokawa M, Takagi S, Kato Y, Suzuki Y, Murata S, Ohashi K. Deguchi T, et al. Among authors: takagi s. Cancers (Basel). 2023 Jun 1;15(11):3013. doi: 10.3390/cancers15113013. Cancers (Basel). 2023. PMID: 37296981 Free PMC article.
Mandibular vascular hamartoma in a cat.
Takagi S, Kagawa Y, Hanazono K, Murakami S, Deguchi T, Izumi Y, Hosoya K, Kim S, Okumura M. Takagi S, et al. J Vet Med Sci. 2018 Sep 26;80(9):1456-1458. doi: 10.1292/jvms.18-0148. Epub 2018 Jul 13. J Vet Med Sci. 2018. PMID: 30012929 Free PMC article.
183 results